Wednesday, September 21, 2016

BRIEF-Eleven Biotherapeutics buys Viventia Bio to create oncology company

* Eleven Biotherapeutics acquires Viventia Bio to create

targeted protein therapeutics oncology company

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)